MX2018003349A - Productos de farmaco nasal y metodos de su uso. - Google Patents

Productos de farmaco nasal y metodos de su uso.

Info

Publication number
MX2018003349A
MX2018003349A MX2018003349A MX2018003349A MX2018003349A MX 2018003349 A MX2018003349 A MX 2018003349A MX 2018003349 A MX2018003349 A MX 2018003349A MX 2018003349 A MX2018003349 A MX 2018003349A MX 2018003349 A MX2018003349 A MX 2018003349A
Authority
MX
Mexico
Prior art keywords
drug products
methods
nasal drug
nasal
symptoms
Prior art date
Application number
MX2018003349A
Other languages
English (en)
Inventor
Brenner Weiss Michael
KEEGAN Fintan
Gerard BELL Robert
Crystal Roger
Original Assignee
Adapt Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adapt Pharma Ltd filed Critical Adapt Pharma Ltd
Publication of MX2018003349A publication Critical patent/MX2018003349A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se proporcionan productos de fármaco adaptados para suministro nasal, que comprenden un dispositivo pre-preparado llenado con una composición farmacéutica que comprende un antagonista del receptor opioide. También se proporcionan métodos para tratar la sobredosis de opioides o sus síntomas con los productos de fármaco inventivos.
MX2018003349A 2015-09-17 2016-09-16 Productos de farmaco nasal y metodos de su uso. MX2018003349A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562219955P 2015-09-17 2015-09-17
US201662274536P 2016-01-04 2016-01-04
PCT/US2016/052280 WO2017049181A1 (en) 2015-09-17 2016-09-16 Nasal drug products and methods of their use

Publications (1)

Publication Number Publication Date
MX2018003349A true MX2018003349A (es) 2018-11-12

Family

ID=58289745

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018003349A MX2018003349A (es) 2015-09-17 2016-09-16 Productos de farmaco nasal y metodos de su uso.

Country Status (4)

Country Link
EP (1) EP3349756A4 (es)
CA (1) CA2950687C (es)
MX (1) MX2018003349A (es)
WO (1) WO2017049181A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180193332A1 (en) * 2017-10-09 2018-07-12 Adapt Pharma Operations Limited Low-temperature stable opioid antagonist solutions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003296954A1 (en) * 2002-12-13 2004-07-09 The Regents Of The University Of California Analgesic combination comprising nalbuphine
CN1575795A (zh) * 2003-06-25 2005-02-09 中国人民解放军军事医学科学院毒物药物研究所 盐酸纳洛酮鼻腔喷雾剂
TWI486161B (zh) * 2011-05-13 2015-06-01 Euro Celtique Sa 含那若松（ｎａｌｏｘｏｎｅ）的鼻內藥物劑型
EP3082816B1 (en) * 2013-12-20 2019-03-20 Indivior UK Limited Intranasal naloxone compositions and methods of making and using same
SG10202003562WA (en) * 2014-03-14 2020-05-28 Opiant Pharmaceuticals Inc Nasal drug products and methods of their use

Also Published As

Publication number Publication date
EP3349756A4 (en) 2019-05-15
CA2950687C (en) 2023-02-28
EP3349756A1 (en) 2018-07-25
WO2017049181A1 (en) 2017-03-23
CA2950687A1 (en) 2017-03-17

Similar Documents

Publication Publication Date Title
GB2538682A (en) Nasal drug products and methods of their use
CA186677S (en) Drug delivery device
MX2023000320A (es) Metodos para modular los niveles de farmaco en plasma mediante el uso de eritrohidroxibupropion.
MX2021008113A (es) Composiciones farmaceuticas que comprenden un antagonista de il-4r para usarse en el tratamiento del asma.
FI3886944T3 (fi) Lääkeaineiden antolaite
MX2016009332A (es) Conjugado de farmaco citotoxico-ligando, metodo de preparacion del mismo y uso del mismo.
HRP20191265T8 (hr) Supstituirani 2-tiokso-imidazolidin-4-oni i njihovi spiro analozi, aktivni anti-kancerogeni sastojak, farmaceutska kompozicija, medicinski preparat, metoda za liječenje raka prostate
EP3806939A4 (en) DEVICE FOR USE IN RESPIRATORY MEDICATION ADMINISTRATION
IL268385B (en) Drug delivery devices and drug delivery methods
EP3720522C0 (en) DRUG DELIVERY DEVICE
PH12018502738A1 (en) Compositions, devices, and methods for the treatment of alcohol use disorder
IL291521A (en) An injection device, especially an automatic injector, for the simultaneous administration of several drugs
IL279127A (en) Dispensing devices for drug administration
EP3377004A4 (en) DEVICE AND METHOD FOR IMPROVED DRUG RELIEF
HK1248618A1 (zh) 配量機構和藥物輸送裝置
HK1244734A1 (zh) 劑量設定機構和具有該劑量設定機構的藥物輸送裝置
GB201607778D0 (en) Drug delivery device
MX2018003349A (es) Productos de farmaco nasal y metodos de su uso.
GB201710280D0 (en) Drug delivery apparatus
PL3694585T3 (pl) Urządzenie do podawania leku
PT3650024T (pt) Composição farmacêutica para administração nasal compreendendo rifampicinas para tratar demência
GB201619561D0 (en) Medicament delivery device and system
IL279128A (en) Dispensing devices for drug administration
IL291196A (en) Standards and methods for determining the dose of the drug
AU201814803S (en) Drug delivery device